MRI Fiber Tracking May Be Potential SMA Biomarker for Response to Therapy & Thoughs On Risdiplam - a podcast by SMA News Today

We discuss a study that suggests how MRI fiber tracking may be a potential biomarker of SMA course and response to therapy. Forums Director Kevin Schaefer shares his thoughts on the experimental therapy risdiplam. If FDA-approved, this drug would be the first oral treatment for SMA.

Are you interested in learning more about the latest treatment for spinal muscular atrophy? Visit TreatSMA.com to see how this treatment works, hear about family stories, and learn about the steps to starting treatment. Visit TreatSMA.com.

Further episodes of SMA News & Perspectives

Further podcasts by SMA News Today

Website of SMA News Today